The increased expression of IL6 in H2228 cells resembles a suggested androgen-independent disease progression mechanism in prostate cancer and induces some AR target genes through activation of signal transducer and activator of transcription 3 (STAT3).2 This evidence concerns the gene STAT3 and prostate carcinoma.